341 related articles for article (PubMed ID: 36387907)
1. Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.
Du X; Yang L; Kong L; Sun Y; Shen K; Cai Y; Sun H; Zhang B; Guo S; Zhang A; Wang X
Front Endocrinol (Lausanne); 2022; 13():1037164. PubMed ID: 36387907
[TBL] [Abstract][Full Text] [Related]
2. PPP1CA/YAP/GS/Gln/mTORC1 pathway activates retinal Müller cells during diabetic retinopathy.
Guo Y; Cang X; Zhu L; Zhu M; Li A; Wang Z; Zhang Y; Wang X; Song E
Exp Eye Res; 2021 Sep; 210():108703. PubMed ID: 34280391
[TBL] [Abstract][Full Text] [Related]
3. Metabolic characterization of diabetic retinopathy: An
Jin H; Zhu B; Liu X; Jin J; Zou H
J Pharm Biomed Anal; 2019 Sep; 174():414-421. PubMed ID: 31212142
[TBL] [Abstract][Full Text] [Related]
4. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
[No Abstract] [Full Text] [Related]
5. Metabolomics in Diabetic Retinopathy: From Potential Biomarkers to Molecular Basis of Oxidative Stress.
Jian Q; Wu Y; Zhang F
Cells; 2022 Sep; 11(19):. PubMed ID: 36230967
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics in Diabetic Retinopathy: A Systematic Review.
Hou XW; Wang Y; Pan CW
Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):4. PubMed ID: 34347011
[TBL] [Abstract][Full Text] [Related]
7. Ferrous ascorbate as a potential biomarker for diabetic retinopathy: a vitreous humour metabolomics study.
Liu J; Liu S; Hui P; Teng S; Xie J; Sun Y
BMC Ophthalmol; 2024 Jun; 24(1):270. PubMed ID: 38914965
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic profile of diabetic retinopathy: a GC-TOFMS-based approach using vitreous and aqueous humor.
Wang H; Fang J; Chen F; Sun Q; Xu X; Lin SH; Liu K
Acta Diabetol; 2020 Jan; 57(1):41-51. PubMed ID: 31089930
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory and angiogenic biomarkers in diabetic retinopathy.
Kaštelan S; Orešković I; Bišćan F; Kaštelan H; Gverović Antunica A
Biochem Med (Zagreb); 2020 Oct; 30(3):030502. PubMed ID: 32774120
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of Diabetic Retinopathy.
Ting DS; Tan KA; Phua V; Tan GS; Wong CW; Wong TY
Curr Diab Rep; 2016 Dec; 16(12):125. PubMed ID: 27778251
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes.
Wang Z; Tang J; Jin E; Ren C; Li S; Zhang L; Zhong Y; Cao Y; Wang J; Zhou W; Zhao M; Huang L; Qu J
Front Endocrinol (Lausanne); 2022; 13():986303. PubMed ID: 36157454
[TBL] [Abstract][Full Text] [Related]
12. Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy.
Ancel P; Martin JC; Doukbi E; Houssays M; Gascon P; Righini M; Matonti F; Svilar L; Valmori M; Tardivel C; Venteclef N; Julla JB; Gautier JF; Resseguier N; Dutour A; Gaborit B
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569425
[TBL] [Abstract][Full Text] [Related]
13. Glyceraldehyde-3-phosphate dehydrogenase and glutamine synthetase inhibition in the presence of pro-inflammatory cytokines contribute to the metabolic imbalance of diabetic retinopathy.
Shivashankar G; Lim JC; Acosta ML
Exp Eye Res; 2021 Dec; 213():108845. PubMed ID: 34800480
[TBL] [Abstract][Full Text] [Related]
14. Integration of systematic review, lipidomics with experiment verification reveals abnormal sphingolipids facilitate diabetic retinopathy by inducing oxidative stress on RMECs.
Yuan Z; Tian Y; Zhang C; Wang M; Xie J; Wang C; Huang J
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Nov; 1868(11):159382. PubMed ID: 37659619
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles of human diabetic retinopathy retinal tissue and urine of diabetic retinopathy patients are enriched for the junction plakoglo bin protein.
Mighty J; Rubio-Navarro A; Shi C; Zhou J; Flores-Bellver M; Heissel S; Onwumere O; Einbond L; Gharbaran R; Casper DS; Benito-Martin A; Redenti S
Front Endocrinol (Lausanne); 2022; 13():1077644. PubMed ID: 36686464
[TBL] [Abstract][Full Text] [Related]
16. Effect of the ethyl acetate extract of Sophora flavescens Aiton on diabetic retinopathy based on untargeted retinal metabolomics.
Luo Y; Zhao K; Li Z; Gao Y; Lin M; Li Y; Wang S; Liu Y; Chen L
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 May; 1198():123233. PubMed ID: 35395445
[TBL] [Abstract][Full Text] [Related]
17. Diabetic retinopathy: Proteomic approaches to help the differential diagnosis and to understand the underlying molecular mechanisms.
Csősz É; Deák E; Kalló G; Csutak A; Tőzsér J
J Proteomics; 2017 Jan; 150():351-358. PubMed ID: 27373871
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
[TBL] [Abstract][Full Text] [Related]
19. Proximity Extension Assay (PEA) Platform to Detect Vitreous Biomarkers of Diabetic Retinopathy.
Lamy R; Ma'ayeh S; Chlamydas S; Stewart JM
Methods Mol Biol; 2023; 2678():135-145. PubMed ID: 37326709
[TBL] [Abstract][Full Text] [Related]
20. Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy.
Youngblood H; Robinson R; Sharma A; Sharma S
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
